| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/04/2012 | CN102307904A Conjugates of neurotensin or neurotensin analogs and uses thereof |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/04/2012 | CN102307894A A variant of mite allergen and uses thereof |
| 01/04/2012 | CN102307893A Peptides for vaccine |
| 01/04/2012 | CN102307892A Derivatives of cyclosporin A |
| 01/04/2012 | CN102307594A Treatment of mucositis with kallikrein inhibitors |
| 01/04/2012 | CN102307593A Modulation of axon degeneration |
| 01/04/2012 | CN102307589A Analysis of HCV genotypes |
| 01/04/2012 | CN102307588A Trimerich hiv fusion inhibitors for treating or preventing hiv infection |
| 01/04/2012 | CN102307587A Use of APL-type peptide for treating intestinal inflammatory diseases and type 1 diabetes |
| 01/04/2012 | CN102307586A Compounds and methods for the treatment of autoimmune and inflammatory disease |
| 01/04/2012 | CN102307585A Dipeptide having antiatherosclerotic action |
| 01/04/2012 | CN102307584A YL-based insulin-like growth factors exhibiting high activity at the insulin receptor |
| 01/04/2012 | CN102307582A Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut |
| 01/04/2012 | CN102307571A Clostridial toxin pharmaceutical compositions |
| 01/04/2012 | CN102307562A Methods and compositions for treating P.acnes |
| 01/04/2012 | CN102307561A Use of plant-derived recombinant growth factors in skin care |
| 01/04/2012 | CN102304540A Expression equipment for expressing exogenous protein by secretion in trichoderma reesei and application of expression equipment |
| 01/04/2012 | CN102304527A Enterococcus antigens |
| 01/04/2012 | CN102304516A Pichia pastoris expression product of scygonadin and preparation method thereof |
| 01/04/2012 | CN102304179A GLP-1 and exendin related invention |
| 01/04/2012 | CN102304178A Preparation method and application of African clawed toad antitumor polypeptide |
| 01/04/2012 | CN102304171A Three alpha-conus polypeptides and use thereof |
| 01/04/2012 | CN102304170A Horn polypeptide, and separation method and antioxidation application thereof |
| 01/04/2012 | CN102304169A Antihypertensive polypeptide and use thereof |
| 01/04/2012 | CN102302770A Medical composition for accelerating wound healing |
| 01/04/2012 | CN102302769A Blood-sugar-reducing composition and application thereof |
| 01/04/2012 | CN102302768A Method for preparing brain protein hydrolysate oral liquid |
| 01/04/2012 | CN102302767A Novel extraction method of cerebroprotein hydrolysate solution |
| 01/04/2012 | CN102302493A Methods to mobilize progenitor/stem cells |
| 01/04/2012 | CN102302446A Recombinant human growth hormone injection capable of being directly used |
| 01/04/2012 | CN101972224B Eye in-situ gel |
| 01/04/2012 | CN101628113B Application of earthworm fibrinolytic enzyme in resistance to liver fibrosis |
| 01/04/2012 | CN101554472B Novel medical compound being capable of synergetically suppressing growth of tumors |
| 01/04/2012 | CN101475632B Recombinant Ganoderma lucidum immunoregulation protein with antineoplastic function and medicinal preparation thereof |
| 01/04/2012 | CN101461939B Angiotensin converting enzyme inhibitor and preparation thereof |
| 01/04/2012 | CN101433515B High-efficient low-toxicity ultrasonic microvesicle for carrying ricin A chain and preparation method thereof |
| 01/04/2012 | CN101384709B Anti-inflammatory peptides |
| 01/04/2012 | CN101307103B Purification method of follicle stimulating hormone |
| 01/04/2012 | CN101273134B Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes and method |
| 01/04/2012 | CN101166539B Compositions and methods involving MDA-7 for the treatment of cancer |
| 01/04/2012 | CN101022833B Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations |
| 01/03/2012 | US8088915 Methods for modulating IKKα activity |
| 01/03/2012 | US8088912 A polyvalent multimeric complex formed from a plurality of circularly permuted chimeric pRNA molecules, each carrying a stabilized biologically active moiety; degradation resistant stabilized ribozyme is correctly folded such that it remains intracellularly active |
| 01/03/2012 | US8088909 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 01/03/2012 | US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof |
| 01/03/2012 | US8088899 Human granulocyte-colony stimulating factor isoforms |
| 01/03/2012 | US8088894 Methods and compositions for Mycoplasma pneumoniae exotoxins |
| 01/03/2012 | US8088893 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 01/03/2012 | US8088892 Inhibitors of proteins from the Rho-GEF family |
| 01/03/2012 | US8088890 Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/03/2012 | US8088889 Teneurin c-terminal associated peptides (TCAP) and uses thereof |
| 01/03/2012 | US8088888 Method of treatment of a fungal infection with poly arginine peptides |
| 01/03/2012 | US8088887 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 01/03/2012 | US8088886 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/03/2012 | US8088787 Methods related to the treatment of neurodegenerative and inflammatory conditions |
| 01/03/2012 | US8088741 Compounds for enzyme inhibition |
| 01/03/2012 | US8088740 Gold binding peptides and shape-and size-tunable synthesis of gold nanostructures |
| 01/03/2012 | US8088739 Method of fixing rail molecule and nano transport device |
| 01/03/2012 | US8088738 Thermostable alpha1-antitrypsin mutein with a disulfide bond and the method for preparing it |
| 01/03/2012 | US8088737 Treating a cancer, in particular breast cancer, that overexpresses Her-2 by administering an ADAM inhibitor; novel variants of ADAM15 and ADAM15; synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds |
| 01/03/2012 | US8088736 CTLA-4 protein variants |
| 01/03/2012 | US8088735 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 01/03/2012 | US8088734 Bioavailability; amidated in situ; adjustment of pH; protective barrier for stomach |
| 01/03/2012 | US8088733 Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders |
| 01/03/2012 | US8088732 Compositions comprising physiologic concentrations of cytokines |
| 01/03/2012 | US8088731 Use of GLP-1 compound for treatment of critically ill patients |
| 01/03/2012 | US8088730 Ghrelin variant protein |
| 01/03/2012 | US8088729 Anti-viral griffithsin compounds, compositions and methods of use |
| 01/03/2012 | US8088728 Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract |
| 01/03/2012 | US8088727 Method for reducing the risk, lessening the symptom, or delaying the onset of insulin resistance by administering SS-31 |
| 01/03/2012 | US8088726 Process for producing sustained-release composition |
| 01/03/2012 | US8088626 Chiral selectors for separating enantiomers of a compound |
| 01/03/2012 | US8088597 Peptide IPP is generated in high yields from preferably a small molecular weight protein having a high amount of -I-P-P- compared to -V-P-P- in its amino acid sequence; preferably the GMP fraction of kappa-casein is used; process comprises a single enzyme incubation step |
| 01/03/2012 | US8088571 Methods of reducing a viral infection and kits therefore |
| 01/03/2012 | US8088569 Immunogens for treatment of neoplastic and infectious disease |
| 01/03/2012 | US8088412 Intralymphatic chemotherapy drug carriers |
| 01/03/2012 | US8088407 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 01/03/2012 | US8088390 Methods for the early diagnosis of ovarian cancer |
| 01/03/2012 | US8088389 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 01/03/2012 | US8088388 Complexing; water in oil emulsion; immunostimulant |
| 01/03/2012 | US8088373 Autocrine growth factor receptor antibodies and methods |
| 01/03/2012 | US8088372 Thrombin mutant |
| 01/03/2012 | US8088371 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma |
| 01/03/2012 | US8088368 Antiviral compounds |
| 01/03/2012 | US8088361 Treatment of allergic rhinitis in mammals with Clostridia neurotoxins |
| 01/03/2012 | US8088360 Treatment of infectious rhinitis in mammals with clostridia neurotoxins |
| 01/03/2012 | US8088160 Drug-eluting intravascular prostheses and methods of use |
| 01/03/2012 | CA2636432C Peptides and compounds that bind to a thrombopoietin receptor |
| 01/03/2012 | CA2632556C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/03/2012 | CA2579619C Radio-opaque polymeric biomaterials |
| 01/03/2012 | CA2539816C Antigens for an east coast fever vaccine |
| 01/03/2012 | CA2528160C Use of 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl) piperazine for neuronal regeneration and functional recovery |
| 01/03/2012 | CA2516314C Liquid growth hormone formulation and process of preparation thereof |
| 01/03/2012 | CA2508932C Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 01/03/2012 | CA2504327C Templated native silk smectic gels |
| 01/03/2012 | CA2501087C Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
| 01/03/2012 | CA2499622C Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 01/03/2012 | CA2490200C 2' and 3'-nucleoside prodrugs for treating flaviviridae infections |
| 01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |